Chongqing Taiji Industry (Group) Co., Ltd. (600129.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 13.42

From 52W high−36.53%

Volume7.01M

Market capCNY 7.84B

P/E (TTM)65.0x

P/S (TTM)0.7x

Div yield—

Key dataSep 18, 2026

Open

CNY 13.42

From 52W high

−36.53%

Volume

7.01M

Market cap

CNY 7.84B

ValuationView details →

P/E (Fwd)

6.3x

EV/EBITDA

19.2x

P/E (TTM)

65.0x

RSI (14)

39.8

MomentumView details →

1D Return

−5.71%

YTD Return

−25.43%

ValuationView details →

P/E (Fwd)

6.3x

P/E (TTM)

65.0x

EV/EBITDA

19.2x

EV/Sales

1.2x

P/S (TTM)

0.7x

P/B (TTM)

2.2x

ProfitabilityView details →

Gross Margin

31.33%

Net Margin

1.09%

EBITDA Margin

6.20%

ROE (TTM)

3.13%

ROA (TTM)

0.75%

Asset Turnover

0.70x

GrowthView details →

Revenue YoY

−7.32%

EPS YoY

+166.03%

FCF YoY

+90.15%

Revenue CAGR 3Y

−9.42%

EPS CAGR 3Y

−29.95%

EBITDA YoY

—

MomentumView details →

1D Return

−5.71%

YTD Return

−25.43%

1Y Return

−37.89%

RSI (14)

39.8

vs 50D SMA

−11.32%

vs 200D SMA

−16.51%

Capital & dividendView details →

Debt/Equity

1.49x

Current Ratio

0.74x

Quick Ratio

0.51x

Div Yield

—

Div Rate

—

Div Growth 1Y

+200.00%

EarningsView details →

EPS (Actual)

CNY 0.04

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

10.20B

Net Income (TTM)

111.65M

Op. CF (TTM)

346.97M

Next earningsOct 23, 2026 →

Latest newsMore news →

Taiji Group announced its 2026 half-year results: net profit attributable to shareholders was 87.8573 million yuan, down 36.70% year-on-year.26d ago

Taiji Group's controlling subsidiary Southwest Pharmaceutical received a drug registration certificate from the National Medical Products Administration for butorphanol tartrate injection, in specifications of 1ml:1mg and 2ml:4mg, for the treatment of cancer pain and postoperative pain.41d ago

Similar companies

华北制药600812.SH SSY Group Limited02005.HK 上海谊众688091.SH 汇宇制药-W688553.SH 鲁抗医药600789.SH 阳光诺和688621.SH Find similar companies →

Latest newsMore news →

Taiji Group announced its 2026 half-year results: net profit attributable to shareholders was 87.8573 million yuan, down 36.70% year-on-year.26d ago Taiji Group's controlling subsidiary Southwest Pharmaceutical received a drug registration certificate from the National Medical Products Administration for butorphanol tartrate injection, in specifications of 1ml:1mg and 2ml:4mg, for the treatment of cancer pain and postoperative pain.41d ago